General form of registration statement for all companies including face-amount certificate companies

Stockholders' Deficit (Details Narrative)

v3.19.3.a.u2
Stockholders' Deficit (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 24, 2019
Jul. 19, 2019
Jun. 24, 2019
Apr. 14, 2016
May 31, 2019
Sep. 30, 2019
Sep. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Aug. 31, 2019
Jul. 02, 2019
Sep. 21, 2018
Sep. 20, 2018
Aug. 29, 2018
Jan. 23, 2018
Jan. 22, 2018
Dec. 09, 2014
Reverse stock split one-for-five hundred (1:500)   one-for-five hundred (1:500)                            
Common stock, shares authorized 100,000,000   100,000,000     100,000,000   100,000,000 100,000,000     4,000,000,000 400,000,000   400,000,000 100,000,000  
Common stock, par value $ 0.001   $ 0.001     $ 0.001   $ 0.001 $ 0.001                
Preferred stock, shares authorized           1,500,005   1,500,005 1,500,005               500,000
Preferred stock, par value           $ 0.01   $ 0.01 $ 0.01                
Common stock issued during period   20,000       181,939                      
Debt conversion price per share           $ 0.704         $ 0.4725            
Conversion Price, Increase           0.906                      
Conversion Price, Decrease           $ 0.45                      
Convertible note issued during the period           $ 123,713 $ 1,413,318 $ 3,350,783 $ 2,770,188                
Common stock reserved for future issuances           20,500,465                      
Share issued price per share   $ 1.99                              
Proceeds from issuance of common stock   $ 39,800           $ 1,100,380                
Consulting expenses           $ 39,800                      
Number of restricted shares issued         78,000                        
Share based compensation arrangement by share based payment award options grant date fair value       $ 3,924,880                          
Share Based Compensation           $ 114,904                    
Stock Options [Member]                                  
Granted exercise price           $ 76.37                      
Share Based Compensation         $ 20,718                        
Grant options to purchase           59,644                      
Exercise price         $ 4.65                        
Risk free rate         2.42%                        
Fair value term         10 years                        
Expected volatility         268.00%                        
Option granted value         $ 248,620                        
Unvested stock option recongized           $ 217,542                      
Warrant [Member]                                  
Warrants to purchase common stock               59   450,000       24      
Warrant exercise price                   $ 2.25              
Warrants outstanding and exercisable           975,059                      
Warrants expiration term description           As of September 30, 2019, there were 975,059 warrants outstanding and exercisable with expiration dates commencing May 2020 and continuing through August 2024, with a weighted average exercise price per share of $3.39.   Expiration dates commencing May 2020 and continuing through November 2020                  
Warrants Two [Member]                                  
Warrants to purchase common stock                   300,000              
Warrant exercise price                   $ 3.33              
Warrants Three [Member]                                  
Warrants to purchase common stock                   225,000              
Warrant exercise price                   $ 4.50              
Restricted Stock Units (RSUs) [Member]                                  
Number of restricted shares issued         117,000                        
Granted exercise price         $ 4.25                        
Share based compensation arrangement by share based payment award options grant date fair value         $ 497,240                        
Share Based Compensation           $ 54,386                      
Unrecognized restricted stock units expense           $ 411,777                      
Chief Executive Officer [Member]                                  
Common stock issued during period         58,500                        
Number of restricted shares issued         39,000                        
Granted exercise price       $ 3,750                          
Share based compensation arrangement by share based payment award options grant date fair value       $ 1,962,440                          
Grant options to purchase       572                          
Option Description         The total 58,500 options have a term of 10 years from the date of grant and exercise price ranging from $4.25 to $4.675 per share. 1/3rd of these options shall vest every successive one-year anniversary, provided, that on each such vesting date, the Chief Executive Officer and Chief Scientific Officer are employed by the Company and subject to the other provisions of the employment agreement. The 58,500 stock options were valued using a Black-Scholes model with the following assumptions: stock price at valuation date of $4.25 based on quoted trading price on date of grant, exercise price of $4.65, dividend yield of zero, years to maturity of 10.00, a risk free rate of 2.42%, and expected volatility 268% for a total value of $248,620.                        
Chief Executive Officer [Member] | Stock Options [Member]                                  
Grant options to purchase         39,000                        
Chief Scientific Officer [Member] | Stock Options [Member]                                  
Grant options to purchase         19,500                        
Series A Preferred Stock [Member]                                  
Preferred stock, shares authorized           500,000   500,000 500,000               500,000
Preferred stock, par value           $ 0.01   $ 0.01 $ 0.01                
Preferred stock, shares issued           500,000   500,000 500,000                
Preferred stock, shares outstanding           500,000   500,000 500,000                
Convertible note issued during the period